NewOn, Sales Approval Granted in Vietnam and Taiwan

Body Fat Reduction Health Functional Food
Likely to Be Available for Local Sale Within the First Half of the Year

NewOn, which will merge with Hanil Jin-gong this March, is embarking on full-scale overseas expansion.

NewOn, a company developing new materials for body fat reduction, announced on the 7th that it has obtained sales approval from the Vietnam Food Safety Authority for two products: Cissusphil Diet (tablet form) and CissusHyu Diet (powder form). The Vietnam Food Safety Authority reviewed the safety test data from animal studies conducted domestically by NewOn, as well as the human application test results from the Ministry of Food and Drug Safety (MFDS), for about a year.

NewOn plans to enter the Vietnamese market in partnership with the local e-commerce specialist company ‘Kkun Media’. Additionally, it is pursuing an export contract with ‘Co.op’, the largest online and offline distribution channel in Vietnam, making local sales expected within the first half of this year. Furthermore, NewOn will actively sell through online and offline channels operated by Kkun Media.

In Taiwan, NewOn developed export-only products and began exporting an initial shipment of 7,000 sets to its local partner ‘Gutco’, with plans to sell them on Gutco’s exclusive product mall in the future. Through influencer marketing, the products will also be sold at major local health and beauty (H&B) stores such as Watsons, which has sales of approximately $22 billion (about 29 trillion KRW).

A NewOn representative said, “As the global obesity treatment market rapidly grows with drugs like Wegovy and Mounjaro, the body fat reduction health functional food (HFF) market is also expected to grow continuously alongside it. HFFs have advantages over pharmaceuticals in terms of consumer accessibility, ease of consumption, and lower price burden.”

He added, “Along with the steady seller ‘Cissus Diet’, which has sold over 40 million packs, we hold exclusive raw material supply and sales rights for the new material ‘Diglomera’. We have high expectations for the new product featuring Diglomera, which will be launched in March and shows 1.8 times the efficacy of Cissus with a 22.9% reduction in body fat.”